BiomX Inc.
PHGE
$0.52
-$0.03-5.47%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.61M | 4.40M | 2.41M | 2.42M | 2.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.30M | 7.20M | 8.54M | 7.43M | 7.76M |
| Operating Income | -1.30M | -7.20M | -8.54M | -7.43M | -7.76M |
| Income Before Tax | -19.14M | -13.34M | -9.16M | -6.04M | -7.66M |
| Income Tax Expenses | -- | 1.00K | 3.00K | 2.00K | 1.00K |
| Earnings from Continuing Operations | -19.14M | -13.34M | -9.17M | -6.04M | -7.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.14M | -13.34M | -9.17M | -6.04M | -7.66M |
| EBIT | -1.30M | -7.20M | -8.54M | -7.43M | -7.76M |
| EBITDA | -565.50K | -6.04M | -7.30M | -7.14M | -7.52M |
| EPS Basic | -7.38 | -6.67 | -5.55 | -3.66 | -6.30 |
| Normalized Basic EPS | -5.04 | -0.87 | -3.47 | -2.29 | -3.94 |
| EPS Diluted | -7.38 | -6.67 | -5.55 | -3.66 | -6.30 |
| Normalized Diluted EPS | -5.04 | -0.87 | -3.47 | -2.29 | -3.94 |
| Average Basic Shares Outstanding | 2.60M | 2.00M | 1.65M | 1.65M | 1.22M |
| Average Diluted Shares Outstanding | 2.60M | 2.00M | 1.65M | 1.65M | 1.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |